Camp4 Therapeutics Cash Flow Statement (2023-2026) | CAMP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M-12.07M-12.16M
Share-based Compensation (Quarter) 0.72M0.64M0.86M0.79M1.59M0.80M0.86M1.00M0.98M1.15M1.47M
Gains from Sales and Divestitures (Quarter) 0.04M
Gains from Investment Securities (Quarter) -1.07M0.18M0.09M0.36M0.04M0.25M-0.36M-0.19M
Asset Writedowns and Impairment (Quarter) 0.49M-0.01M
Non-cash Items (Quarter) 6.89M1.00M
Cash from Operations (Quarter) -11.78M-11.14M-13.44M-9.69M-11.29M-14.29M-10.34M-11.22M6.25M-11.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.40M0.43M0.45M0.46M0.47M0.48M0.49M0.48M0.03M
Amortization of Deferred Charges (Quarter) 0.03M0.03M0.02M0.02M0.01M0.11M-0.10M0.00M-0.00M0.00M
Depreciation & Amortization (CF) (Quarter) 0.43M0.44M0.42M0.42M0.42M0.42M0.43M0.42M0.37M0.52M
Change in Working Capital
Change in Account Payables (Quarter) -0.15M0.98M-1.04M1.08M-0.86M0.17M-0.19M-0.55M-0.47M0.59M
Change in Accured Expenses (Quarter) 0.56M0.45M-1.48M0.72M1.84M-2.79M1.03M1.36M1.20M-1.37M
Investing Activities
Capital Expenditures (Quarter) -0.04M0.01M0.16M-0.18M0.28M
Cash from Investing Activities (Quarter) -0.24M-0.01M-0.16M-0.26M-0.28M0.04M
Financing Activities
Other financing activities (Quarter) 0.21M-0.82M14.93M-14.93M
Change in Capital Stock
Shares Issued (Quarter) 0.17M0.00M-0.00M0.00M57.51M
Misc.
Cash from Financing Activities (Quarter) -0.06M-0.20M-0.81M-0.39M73.06M-0.15M0.07M47.38M28.59M0.06M
Change in Cash (Quarter) -12.09M-11.36M-14.41M-10.08M61.51M-14.72M-10.27M36.20M34.88M-10.92M
Free Cash Flow (Quarter) -11.74M-11.16M-13.60M-9.69M-11.11M-14.29M-10.62M-11.22M6.25M-11.00M
Net Cash Flow (Quarter) -12.09M-11.36M-14.41M-10.08M61.51M-14.72M-10.27M36.20M34.83M-10.94M